Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review

Psychometric properties of the Montreal Cognitive Assessment (MoCA) in healthy participants aged 18–70

(2020) Carolien J. W. H. Bruijnen et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients

(2020) Laura Basso et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019

(2020) Walter S. Marcantoni et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

(2019) Maggie Fedgchin et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

(2018) Michael F. Grunebaum et al.   AMERICAN JOURNAL OF PSYCHIATRY

The profile of cognitive impairments in chronic ketamine users

(2018) Xiaoyin Ke et al.   PSYCHIATRY RESEARCH

Neurocognitive and behavioural performance of healthy volunteers receiving an increasing analgesic-range infusion of ketamine

(2018) Amie Hayley et al.   PSYCHOPHARMACOLOGY

Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States

(2018) Deborah S. Hasin et al.   JAMA Psychiatry

Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study

(2018) Yoav Domany et al.   BRITISH JOURNAL OF PSYCHIATRY

Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion

(2018) Mu-Hong Chen et al.   JOURNAL OF AFFECTIVE DISORDERS

Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression

(2018) Yanling Zhou et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

(2018) Maurizio Fava et al.   MOLECULAR PSYCHIATRY

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder

(2018) Hannah Zuckerman et al.   Frontiers in Psychiatry

Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder

(2018) Wei Zheng et al.   JOURNAL OF AFFECTIVE DISORDERS

Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?

(2017) Chittaranjan Andrade   JOURNAL OF CLINICAL PSYCHIATRY

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

(2017) Gerard Sanacora et al.   JAMA Psychiatry

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

(2016) Jaskaran B. Singh et al.   AMERICAN JOURNAL OF PSYCHIATRY

KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT?

(2016) Samuel T. Wilkinson et al.   DEPRESSION AND ANXIETY

Continuation phase intravenous ketamine in adults with treatment-resistant depression

(2016) Jennifer L. Vande Voort et al.   JOURNAL OF AFFECTIVE DISORDERS

Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity

(2016) Runtao Ding et al.   Scientific Reports

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

(2015) Ying Xu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression

(2014) Paulo R. Shiroma et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

(2014) A. McGirr et al.   PSYCHOLOGICAL MEDICINE

Ketamine administration in depressive disorders: a systematic review and meta-analysis

(2014) Guillaume Fond et al.   PSYCHOPHARMACOLOGY

Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation

(2014) Celia J. A. Morgan et al.   Frontiers in Psychiatry

Effects of chronic ketamine use on frontal and medial temporal cognition

(2013) Kahlen W.S. Chan et al.   ADDICTIVE BEHAVIORS

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

(2013) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response

(2013) James W. Murrough et al.   PSYCHOPHARMACOLOGY

Ketamine for Depression: Where Do We Go from Here?

(2012) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study

(2009) Celia J. A. Morgan et al.   ADDICTION